| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| Alliance Medical Corporation |
| 10232 South 51 Street, Phoenix, AZ 85044 * (480) 763-5300 |
| Business Description | The company is a leading reprocessor of disposible medical devices that are used in a variety of medical procedures. |
|
Filing Information Not yet | |||
| To Trade As | ALMC (NASNTL) | Industry | Service (SIC 7389) |
| Type of Stock Offered | Common Shares | Filing Date | 8/23/2001 |
| Domestic Shares Filed | 4,000,000 | Filing Range | $14.00 - $16.00 |
| Foreign Shares Filed | 0 | Offering Amount | $60,000,000 |
| Company Shares | 4,000,000 | Est. Expenses | - - |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| UBS Warburg LLC | Lead Manager | |
| RBC Dominion Securities | Co-manager | (212) 361-2617 |
| U.S. Bancorp Piper Jaffray | Co-manager | (612) 342-6220 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 6 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/1998 | 12/31/1999 | 12/31/2000 | 6/30/2000 | 6/30/2001 | ||
| Revenues | - | - | 4.523 | 5.822 | 6.404 | 3.007 | 6.670 |
| Income from Oper. | - | - | -2.810 | -2.856 | -6.871 | -3.055 | -4.190 |
| Net Income | - | - | -3.728 | -3.006 | -6.731 | -3.067 | -4.306 |
| E.P.S | - | - | -1.430 | 0.920 | -2.320 | -0.660 | -1.740 |
| Revenue Growth (%) | - | - | 28.72 | 9.997 | 121.82 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -7.89 | -1.39 | -3.66 | ||||
| Cash Flow - Inv. | -2.12 | -1.08 | -4.74 | ||||
| Cash Flow - Fin. | 9.14 | 1.62 | 8.43 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 6/30/2001 | Financial Ratios | ||||
| Total Assets | 13.34 | Current Assets | 3.86 | Current Ratio | 0.79 |
| Total Liab. | 39.43 | Current Liab. | 4.87 | Debt Ratio | 295.63% |
| Total Equity | -26.10 | Working Cap. | -1.01 | Debt to Equity Ratio | - |
| Cash | 0.05 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used for general corporate purposes, capital expenditures, working capital, research and development, and expansion. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Snell & Wilmer |
| Bank's Law Firm | Dewey Ballantine |
| Auditor | Deloitte & Touche |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Valley Ventures II, LP | ||
| Entities affiliated with Patricof & Co. Ventures, Inc. | ||
| Entities affiliated with Delphi Ventures | ||
| Entities affiliated with Affinity Ventures | ||
| Coral Partners V, Limited Partnership | ||
| Note: represents ownership of 5% or more prior to the offering. | ||